| Focus: | To be a catalyst for enabling translation of stem cell research into clinical applications, commercial products or public policy. |
| Funding: | $82,819,000 for entire funding period |
| Strength: | 105 researchers and 451 highly qualified personnel |
| Partnership Power: | 228 industry, public service and academic partners |
| Scientific Director: | Dr. Michael Rudnicki |
| Web site: |